期刊文献+

低分子量肝素抗凝血液透析 被引量:9

暂未订购
导出
摘要 在血液透析(HD)过程中,合理使用抗凝剂是保证慢性肾功能衰竭(CRF)患者透析质量的关键。在常规血液透析中,使用普通肝素(UFH)作为抗凝剂在防止血栓形成、保证血液透析疗效方面发挥了重要作用,但有出血危险,长期血液透析可引起胃肠道和其它部位的潜在出血。高危出血患者UFH抗凝血液透析中,出血并发症发生率高;低分子量肝素(LMWH)同UFH相比,其主要是选择性抑制凝血因子Xa而发挥抗凝血作用,其对凝血酶(Ⅱa)的作用较弱,故其具有较强抗血栓形成作用,同时有减少出血危险的潜在性,不增加出血倾向。LMWH疗效安全性优于UFH,
作者 杨洁 张波
出处 《陕西医学杂志》 CAS 2000年第2期90-92,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献12

  • 1[1]Suzuki T,Otak S,Naganuma S,et al. Clinical applications of fragmin (FR-860) in hemodialysis :multi center cooperative study in Japan. Seminals Thrombosis Hemostasis,1990;16 (suppl) : 46
  • 2[2]Anastassiades E, Ireland H, Flynn A, et al. A lowmolecular-weight heparin (kabi 2165,Fragmin) in repeated use for hemodialysis: prevention of clotting and prolongation of the venous conpression time in comparison with commercial unfractionated heparin.Dial Transplant, 1990 ; 5 : 135
  • 3[3]Shuichiro I,Masahiko N,Hidetade K. Study of anti coagulating mechansm of low molecular weight heparin.Thrombosis Research, 1992 ; 65 : 801
  • 4[4]Hirsh T,Levine MN. Low molecular weight heparin.Blood,1992;79 : 1
  • 5[5]Gran E,Siguenza F,Maduell F,et al. Low molecular weight heparin (CY-216)cersus unfraction heparin in chronic hemodiaysis. Nephron, 1992; 62: 13
  • 6[6]Wei SS, Ellis PW,Moetal M, et al. Effect of heparin modeling on delivered hemodialysis therapy. Am J Kid Dis,1994;23 : 389
  • 7[7]Shaldon S,Koch KM. Survival and adequacy in longterm hemodialysis, Nephron, 1991 ; 59 : 353
  • 8[8]Moia M,Graziani G. Rationale for the use of a lowmolecular weight heparin during hemodialysis with polysuphone membrane in uremic patients. Annals Italian MedicineInternational, 1997; 12(2) : 67
  • 9[9]Hall AV, Clark WF, Parbtani A. Heparin-induced thrombocytopenia. Clinical Nephrology, 1992 ; 30: 86
  • 10[10]Versttaete M. Pharmacotherapeutic aspects of unfraction-ated and low molecular weight heparin.Drugs,1990;40: 498

同被引文献32

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部